BR112021025089A2 - Antígenos secretados inovadores para diagnóstico de infecção ativa por babesia microti e babesia duncani em humanos e animais - Google Patents

Antígenos secretados inovadores para diagnóstico de infecção ativa por babesia microti e babesia duncani em humanos e animais

Info

Publication number
BR112021025089A2
BR112021025089A2 BR112021025089A BR112021025089A BR112021025089A2 BR 112021025089 A2 BR112021025089 A2 BR 112021025089A2 BR 112021025089 A BR112021025089 A BR 112021025089A BR 112021025089 A BR112021025089 A BR 112021025089A BR 112021025089 A2 BR112021025089 A2 BR 112021025089A2
Authority
BR
Brazil
Prior art keywords
babesia
infection
innovative
humans
diagnosis
Prior art date
Application number
BR112021025089A
Other languages
English (en)
Portuguese (pt)
Inventor
Ben Mamoun Choukri
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of BR112021025089A2 publication Critical patent/BR112021025089A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112021025089A 2019-06-12 2020-06-12 Antígenos secretados inovadores para diagnóstico de infecção ativa por babesia microti e babesia duncani em humanos e animais BR112021025089A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860662P 2019-06-12 2019-06-12
US201962937645P 2019-11-19 2019-11-19
PCT/US2020/037500 WO2020252313A1 (en) 2019-06-12 2020-06-12 Novel secreted antigens for diagnosis of active babesia microti and babesia duncani infection in humans and animals

Publications (1)

Publication Number Publication Date
BR112021025089A2 true BR112021025089A2 (pt) 2022-02-15

Family

ID=73781883

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021025089A BR112021025089A2 (pt) 2019-06-12 2020-06-12 Antígenos secretados inovadores para diagnóstico de infecção ativa por babesia microti e babesia duncani em humanos e animais

Country Status (8)

Country Link
US (1) US20220236268A1 (https=)
EP (1) EP3983430A4 (https=)
JP (2) JP2022536679A (https=)
CN (1) CN114072419A (https=)
AU (1) AU2020292378A1 (https=)
BR (1) BR112021025089A2 (https=)
CA (1) CA3143027A1 (https=)
WO (1) WO2020252313A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220341928A1 (en) * 2021-04-23 2022-10-27 Id-Fish Technology, Inc. Diagnosis of babesia using babesia recombinant proteins
CN119462946B (zh) * 2024-10-21 2025-10-03 华中农业大学 抗邓肯巴贝斯虫ald蛋白的单克隆抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053016A2 (en) * 2001-01-05 2002-07-11 Corixa Corporation Compounds and methods for the diagnosis and treatment of babesia infection
US7704508B2 (en) * 2007-09-14 2010-04-27 New York Blood Center Babesia subtilisin
CN104845981B (zh) * 2015-05-25 2018-06-19 中国疾病预防控制中心寄生虫病预防控制所 田鼠巴贝虫Bm1524抗原及其应用
US20180372742A1 (en) * 2015-12-10 2018-12-27 Immport Therapeutics, Inc. Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test
CN108893476B (zh) * 2018-06-28 2022-07-05 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 田鼠巴贝虫2d97抗原蛋白及其应用

Also Published As

Publication number Publication date
AU2020292378A1 (en) 2022-01-06
JP2025186283A (ja) 2025-12-23
CA3143027A1 (en) 2020-12-17
EP3983430A4 (en) 2023-10-11
JP2022536679A (ja) 2022-08-18
EP3983430A1 (en) 2022-04-20
WO2020252313A1 (en) 2020-12-17
US20220236268A1 (en) 2022-07-28
CN114072419A (zh) 2022-02-18

Similar Documents

Publication Publication Date Title
Sid et al. Mycoplasma gallisepticum modifies the pathogenesis of influenza A virus in the avian tracheal epithelium
Olsen et al. Effect of collection material and sample processing on pig oral fluid testing results
Psaroulaki et al. Coxiella burnetii in wildlife and ticks in an endemic area
MA31991B1 (fr) Anticorps contre le virus de la grippe et procedes pour leur utilisation
BR112012012160A2 (pt) material e métodos para tratar ou prevenir doenças associadas ao her-3
Kamyingkird et al. Prevalence and risk factors associated with Dirofilaria immitis infection in dogs and cats in Songkhla and Satun provinces, Thailand
BR112021025089A2 (pt) Antígenos secretados inovadores para diagnóstico de infecção ativa por babesia microti e babesia duncani em humanos e animais
Locher et al. Longitudinal Dichelobacter nodosus status in 9 sheep flocks free from clinical footrot
Dos Santos et al. Detection of Brucella sp. infection through serological, microbiological, and molecular methods applied to buffaloes in Maranhão State, Brazil
Hartady et al. Clinical human brucellosis in Malaysia: a case report
Varges et al. Interference of intradermal tuberculin tests on the serodiagnosis of paratuberculosis in cattle
Sarker et al. Seroprevalence and molecular diagnosis of Brucella abortus and Brucella melitensis in Bangladesh
Marassi et al. The use of a Gamma-Interferon assay to confirm a diagnosis of bovine tuberculosis in Brazil
Wells et al. Recent developments in the diagnosis of ectoparasite infections and disease through a better understanding of parasite biology and host responses
Surdel et al. Heterologous production of the adhesin LIC13411 from pathogenic Leptospira facilitates binding of non-pathogenic Leptospira in vitro and in vivo
Gurung et al. Immunoreactivity of protein tyrosine phosphatase A (PtpA) in sera from sheep infected with Mycobacterium avium subspecies paratuberculosis
Kushawaha et al. Nipah virus and its outbreaks in tropical areas
Ghoneim et al. Molecular and Serological detection of the most common Brucella species infection in bovine and human in Egypt
Charles et al. Prevalence of bovine brucellosis, tuberculosis and dermatophilosis among cattle from Benins main dairy basins
El-Sify et al. Sero-diagnosis of bovine tuberculosis by ELISA using bovine PPD and ST. CF.
Shirazi et al. Molecular detection of Brucella spp in goat and sheep milk samples from apparently healthy and infected animals
Gangani et al. Humoral immune response and changes in peritoneal cell populations in rats immunized against two Leptospira serovars; serovar patoc and serovar pyrogenes
Adamu et al. Serological survey of Brucella antibodies in cattle breeding herds in Northeastern Nigeria
RU2601372C2 (ru) Способ отбора доноров крови для получения плазмы с целью лечения пациентов с инфекционными заболеваниями и осложнениями после оперативных вмешательств, травм и ожогов
WO2010128232A3 (fr) Méthode de diagnostic des infections à propionibacterium acnes